Aimmune soars 172% after Nestle agrees to acquire for $2.6 billion - Business Insider

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 51%

Business News News

Business Business Latest News,Business Business Headlines

Aimmune Therapeutics soars 172% after Nestle agrees to acquire the peanut allergy treatment company for $2.6 billion

follow-on investment in the company. Nestle had originally invested in Aimmune in 2016.

Nestle expects the acquisition to be accretive to its organic growth in 2021, and accretive to cash earnings by 2022 or 2023, the company said. Nestle will launch a tender offer to acquire all shares it doesn't already own for $34.50, representing a 174% premium to Aimmune's Friday closing price of $12.60, and a total enterprise value of $2.6 billion.

Nestle will finance the acquisition with cash on hand and expects the transaction to close in the fourth quarter of 2020.Something is loading.By clicking ‘Sign up’, you agree to receive marketing emails from Business Insider as well as other partner offers and accept our

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Do You Want To create 3d construction logo animation video ? Please Contact Me: LogoAnimation Construction logo animation Character Logo Animation top logo animation

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 729. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Business Insider's biggest advertising and media stories for August 31 - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web. Huge Data Harvesting Great proposition. Would love to see a real Amazon competitor. Whilst I don’t use Tik Tok, there’s no denying it’s monetisation potential.
Source: BusinessInsider - 🏆 729. / 51 Read more »

SUCCESS INSIDER: Harvard grads franchises, GT Dave's kombucha, culture - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web. lockdown dems would shut down the economy... a second time... The democrat party is insane. By creating more & consuming less, Capitalism isnt a problem an individuals consumerism is Affluent Harvard grads take the easy way to fast money, letting burger flippers know they will never, ever work their way to franchisee.
Source: BusinessInsider - 🏆 729. / 51 Read more »